Micronosesp. z o.o. in liquidation
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2023-04-17
Share capital
25,000.00 PLN
Registered address
ul. Energetyczna 6/7, 53-330 Wrocław, Poland
Website
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Udziałowcy będą podejmowali działania zmierzające do likwidacji spółki.
From the notes
| Profit allocation | Covers prior losses | |
| Related parties | 1 items |
Filing timeliness
Financial statements were filed on time, on average 43 days early.
- 202529/03/2026
- 202413/07/2025
- 202326/06/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Voivodeship · Dolnośląskie31,296 / 41,331
Top 76%
Country · Poland377,598 / 495,850
Top 76%
Results vs industry
Revenue
This companyUSD 23.47kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD 1.97kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 20.55kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 1.71kMedianUSD 133.19kAverageUSD 3.03m
Industry
Trademarks
Micronose holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2023.
| Mark | Protected until | |
|---|---|---|
| Micronose | Jul 19, 2033 |
Authorized Representatives
Sabina Górska – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sabina Barbara Górskaage 44 | 225 | $13.51 | 0.2% |
Dorota Pierzeckaage 45 | 50 | $13.51 | 0.2% |
Agnieszka Maria Razimage 37 | 225 | $13.51 | 0.2% |
Others | 82,833 | $6,712.59 | 99.4% |
The articles of association require board approval for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 17, 2026 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| GenomtecS.A. | $54,746.36 | genomtec.com | ||
| Immbionicsp. z o.o. | $31,756.23 | immbionic.com.pl | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Centrum Transferu Technologii Meditransfer Iitdsp. z o.o. | $228.56 | iitd.pan.wroc.pl | ||
| Olenasp. z o.o. | – | imsolutions.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-10 | Name change (Micronose → Micronose Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2026-04-09 | Liquidation opened | |
| 2024-01-05 | Share capital increase (16,000.00 PLN → 25,000.00 PLN) | |
| 2024-01-05 | PKD change (Removed: 9 codes; Added: 9 codes) | |
| 2023-04-17 | Entered in the register |
FAQ
The main business activity of Micronose focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on April 17, 2023.
The headquarters is located at: ul. Energetyczna 6, 53-330 Wrocław.
The share capital of the company is PLN 25,000 (approx. $6,753).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $23,465, representing an increase of 1768.7% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $1,973.
The largest operating cost category falls under materials and energy. This category amounted to $15,739 in 2025, representing 77% of all operating expenses.
Last updated: 2026-04-10
